Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Experimental cancer drug resurfaces

Nature (2010)Cite this article

Subjects

Small clinical trial yields promising results for controversial molecule.

A compound shown to shrink tumours in rats by correcting metabolic oddities found in cancer cells has now been tested in five patients with brain cancer.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

References

  1. Michelakis, E. D. et al. Sci. Trans. Med. 2, 31ra34 (2010).

    Article  Google Scholar 

  2. Bonnet, S. et al. Cancer Cell 11, 37-51 (2007).

    Article  Google Scholar 

Download references

Authors
  1. Heidi Ledford
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related external links

DCA research information

Lewis Cantley's webpage

Leonard Lichtenfeld’s cancer blog

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ledford, H. Experimental cancer drug resurfaces. Nature (2010). https://doi.org/10.1038/news.2010.236

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news.2010.236

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer